Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological Profiling
Nadine Álvarez(Hackensack Meridian Health), David S. Perlin(Center for Discovery), David B. Olsen, John A. McCauley(Fox Chase Cancer Center), Valerie W. Shurtleff(United States Military Academy), Risha Rasheed(Hackensack Meridian Health), Nicholas G. Fox(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven Park(Hackensack Meridian Health), Andrew M. Nelson(Hackensack Meridian Health), Carolyn Bahnck-Teets(Merck & Co., Inc., Rahway, NJ, USA (United States)), M. E. Layton(Merck & Co., Inc., Rahway, NJ, USA (United States)), Craig A. Parish(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gregory C. Adam(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tamara D. Cabalu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Krista Getty(Merck & Co., Inc., Rahway, NJ, USA (United States)), John F. Fay(Merck & Co., Inc., Rahway, NJ, USA (United States)), John A. Howe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xiaoyan Zhou(Affiliated Hospital of Shaanxi University of Chinese Medicine), Todd Mayhood(Merck & Co., Inc., Rahway, NJ, USA (United States)), Enriko Dolgov(Hackensack Meridian Health), Christine Burlein(Merck & Co., Inc., Rahway, NJ, USA (United States)), Vijeta Sharma(Hackensack Meridian Health), Christopher W. Boyce(Scripps Research Institute), Imad Salhab(Merck & Co., Inc., Rahway, NJ, USA (United States)), Fatima Nizar(Hackensack Meridian Health), Khushboo Sahay(Hackensack Meridian Health), Daniel V. Iwamoto(Merck & Co., Inc., Rahway, NJ, USA (United States)), Matthew Zimmerman(Hackensack Meridian Health), Shih Lin Goh(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 1
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
|Proceedings of the National Academy of Sciences|1999|326
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272